-+ 0.00%
-+ 0.00%
-+ 0.00%

Travere Therapeutics director Jeffrey A. Meckler disposes of common shares worth $1.31 million

PUBT·09/11/2026 20:06:26
Listen to the news
Travere Therapeutics director Jeffrey A. Meckler disposes of common shares worth $1.31 million
  • Travere Therapeutics director Jeffrey A. Meckler exercised stock options on Sep. 10, 2026 for 20,000 common shares at USD 17.44–26.52.
  • He sold 20,000 common shares the same day at weighted average prices of USD 65.39–68.09.
  • Directly held common shares fell to 91,500 following the transactions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Travere Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001506916-26-000004), on September 11, 2026, and is solely responsible for the information contained therein.